Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Panel Votes on Pimavanserin for Alzheimer Disease Psychosis
Actions Against Physician Licenses Due to Substance Use Down
Pediatric Suspected Suicides by Poisoning Up, Including Among Younger Ages
Trial Evaluating Zuranolone for Postpartum Depression Meets All Endpoints
Drug Therapy for Peds Psych Disorders, Later SUD Risk Examined
Drug Therapy for AUD May Cut Risk for Alcohol-Related Liver Disease
Clinical Predictors Could Guide Lithium Dosage in Bipolar Disorder
Responses to Screening for Suicide Risk May Differ for Gun Owners
Serotonergic Antidepressants in Pregnancy Not Tied to Neonatal Seizures
TMS Device NeuroStar Cleared for Obsessive-Compulsive Disorder
April 2022: Drug Pipeline Updates
April 2022: Notable Drug Approvals
Nonstimulant ADHD Treatment Option Approved for Adults
Quviviq Now Available for Adults With Insomnia
New Caplyta Dosage Strengths Approved for Specific Patient Populations
Antidepressants Not Tied to Long-Term Boost in Quality of Life
FDA Delays Decision on Long-Acting Schizophrenia Treatment, Issues CRL
Psychiatric Disorders May Up SARS-CoV-2 Breakthrough Infection Risk